US Stock MarketDetailed Quotes

VCEL Vericel

Watchlist
  • 46.680
  • +1.770+3.94%
Close Jul 5 16:00 ET
  • 45.650
  • -1.030-2.21%
Post 16:33 ET
2.27BMarket Cap4668.00P/E (TTM)

Vericel Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
25.02%51.28M
20.17%197.52M
23.35%65M
18.24%45.58M
23.96%45.92M
13.70%41.02M
5.24%164.37M
10.72%52.69M
11.72%38.55M
-6.26%37.05M
Operating revenue
25.02%51.28M
20.66%197.52M
23.35%65M
18.93%45.58M
24.70%45.92M
14.41%41.02M
6.94%163.7M
12.00%52.69M
13.67%38.33M
-4.79%36.83M
Cost of revenue
9.86%15.93M
13.49%61.94M
14.15%16.49M
12.43%14.97M
12.61%15.98M
14.86%14.5M
8.81%54.58M
6.53%14.45M
7.33%13.32M
12.55%14.19M
Gross profit
33.31%35.35M
23.49%135.58M
26.82%48.51M
21.30%30.61M
31.01%29.94M
13.08%26.52M
3.55%109.79M
12.39%38.25M
14.19%25.23M
-15.07%22.85M
Operating expense
17.64%40.82M
11.98%142.04M
11.23%35.78M
11.38%35.67M
12.42%35.9M
12.93%34.7M
11.39%126.85M
7.60%32.16M
18.34%32.02M
4.23%31.94M
Selling and administrative expenses
16.67%34.4M
13.18%121M
14.70%30.88M
11.17%29.99M
12.91%30.65M
14.00%29.49M
9.54%106.9M
3.67%26.92M
18.44%26.98M
3.64%27.14M
Research and development costs
23.14%6.42M
5.51%21.04M
-6.56%4.9M
12.49%5.68M
9.62%5.25M
7.24%5.21M
22.45%19.94M
33.66%5.25M
17.79%5.05M
7.71%4.79M
Operating profit
33.18%-5.46M
62.11%-6.46M
109.22%12.73M
25.50%-5.06M
34.36%-5.96M
-12.43%-8.18M
-117.19%-17.06M
46.95%6.09M
-36.83%-6.79M
-143.55%-9.08M
Net non-operating interest income expense
131.84%1.61M
313.54%4.03M
137.04%1.28M
369.20%1.11M
639.06%946K
891.43%694K
343.18%975K
800.00%540K
451.16%237K
204.76%128K
Non-operating interest income
110.01%1.76M
245.41%4.63M
88.20%1.44M
269.01%1.26M
639.86%1.1M
853.41%839K
498.66%1.34M
1,150.82%763K
677.27%342K
244.19%148K
Non-operating interest expense
5.52%153K
63.93%600K
-30.04%156K
42.86%150K
645.00%149K
705.56%145K
9,050.00%366K
22,200.00%223K
10,400.00%105K
1,900.00%20K
Other net income (expense)
41.67%-7K
-32.63%64K
2,833.33%82K
80.00%-1K
44.44%-5K
-110.71%-12K
82.69%95K
-137.50%-3K
61.54%-5K
66.67%-9K
Other non- operating income (expenses)
41.67%-7K
-32.63%64K
2,833.33%82K
80.00%-1K
44.44%-5K
-110.71%-12K
82.69%95K
-137.50%-3K
61.54%-5K
66.67%-9K
Income before tax
48.47%-3.86M
85.19%-2.37M
112.82%14.09M
39.81%-3.95M
43.99%-5.02M
-5.70%-7.5M
-110.87%-15.99M
57.33%6.62M
-32.95%-6.56M
-141.33%-8.96M
Income tax
12.90%814K
57.14%1.1M
-1,461.90%-286K
749.55%721K
314.72%700K
21K
Net income
48.47%-3.86M
80.96%-3.18M
119.40%12.99M
44.35%-3.66M
43.99%-5.02M
-5.70%-7.5M
-123.65%-16.71M
30.58%5.92M
-33.38%-6.58M
-136.74%-8.96M
Net income continuous Operations
48.47%-3.86M
80.96%-3.18M
119.40%12.99M
44.35%-3.66M
43.99%-5.02M
-5.70%-7.5M
-123.65%-16.71M
30.58%5.92M
-33.38%-6.58M
-136.74%-8.96M
Minority interest income
Net income attributable to the parent company
48.47%-3.86M
80.96%-3.18M
119.40%12.99M
44.35%-3.66M
43.99%-5.02M
-5.70%-7.5M
-123.65%-16.71M
30.58%5.92M
-33.38%-6.58M
-136.74%-8.96M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
48.47%-3.86M
80.96%-3.18M
119.40%12.99M
44.35%-3.66M
43.99%-5.02M
-5.70%-7.5M
-123.65%-16.71M
30.58%5.92M
-33.38%-6.58M
-136.74%-8.96M
Basic earnings per share
50.00%-0.08
80.00%-0.07
107.69%0.27
42.86%-0.08
42.11%-0.11
-6.67%-0.16
-118.75%-0.35
30.00%0.13
-27.27%-0.14
-137.50%-0.19
Diluted earnings per share
50.00%-0.08
80.00%-0.07
125.00%0.27
42.86%-0.08
42.11%-0.11
-6.67%-0.16
-118.75%-0.35
33.33%0.12
-27.27%-0.14
-137.50%-0.19
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue 25.02%51.28M20.17%197.52M23.35%65M18.24%45.58M23.96%45.92M13.70%41.02M5.24%164.37M10.72%52.69M11.72%38.55M-6.26%37.05M
Operating revenue 25.02%51.28M20.66%197.52M23.35%65M18.93%45.58M24.70%45.92M14.41%41.02M6.94%163.7M12.00%52.69M13.67%38.33M-4.79%36.83M
Cost of revenue 9.86%15.93M13.49%61.94M14.15%16.49M12.43%14.97M12.61%15.98M14.86%14.5M8.81%54.58M6.53%14.45M7.33%13.32M12.55%14.19M
Gross profit 33.31%35.35M23.49%135.58M26.82%48.51M21.30%30.61M31.01%29.94M13.08%26.52M3.55%109.79M12.39%38.25M14.19%25.23M-15.07%22.85M
Operating expense 17.64%40.82M11.98%142.04M11.23%35.78M11.38%35.67M12.42%35.9M12.93%34.7M11.39%126.85M7.60%32.16M18.34%32.02M4.23%31.94M
Selling and administrative expenses 16.67%34.4M13.18%121M14.70%30.88M11.17%29.99M12.91%30.65M14.00%29.49M9.54%106.9M3.67%26.92M18.44%26.98M3.64%27.14M
Research and development costs 23.14%6.42M5.51%21.04M-6.56%4.9M12.49%5.68M9.62%5.25M7.24%5.21M22.45%19.94M33.66%5.25M17.79%5.05M7.71%4.79M
Operating profit 33.18%-5.46M62.11%-6.46M109.22%12.73M25.50%-5.06M34.36%-5.96M-12.43%-8.18M-117.19%-17.06M46.95%6.09M-36.83%-6.79M-143.55%-9.08M
Net non-operating interest income expense 131.84%1.61M313.54%4.03M137.04%1.28M369.20%1.11M639.06%946K891.43%694K343.18%975K800.00%540K451.16%237K204.76%128K
Non-operating interest income 110.01%1.76M245.41%4.63M88.20%1.44M269.01%1.26M639.86%1.1M853.41%839K498.66%1.34M1,150.82%763K677.27%342K244.19%148K
Non-operating interest expense 5.52%153K63.93%600K-30.04%156K42.86%150K645.00%149K705.56%145K9,050.00%366K22,200.00%223K10,400.00%105K1,900.00%20K
Other net income (expense) 41.67%-7K-32.63%64K2,833.33%82K80.00%-1K44.44%-5K-110.71%-12K82.69%95K-137.50%-3K61.54%-5K66.67%-9K
Other non- operating income (expenses) 41.67%-7K-32.63%64K2,833.33%82K80.00%-1K44.44%-5K-110.71%-12K82.69%95K-137.50%-3K61.54%-5K66.67%-9K
Income before tax 48.47%-3.86M85.19%-2.37M112.82%14.09M39.81%-3.95M43.99%-5.02M-5.70%-7.5M-110.87%-15.99M57.33%6.62M-32.95%-6.56M-141.33%-8.96M
Income tax 12.90%814K57.14%1.1M-1,461.90%-286K749.55%721K314.72%700K21K
Net income 48.47%-3.86M80.96%-3.18M119.40%12.99M44.35%-3.66M43.99%-5.02M-5.70%-7.5M-123.65%-16.71M30.58%5.92M-33.38%-6.58M-136.74%-8.96M
Net income continuous Operations 48.47%-3.86M80.96%-3.18M119.40%12.99M44.35%-3.66M43.99%-5.02M-5.70%-7.5M-123.65%-16.71M30.58%5.92M-33.38%-6.58M-136.74%-8.96M
Minority interest income
Net income attributable to the parent company 48.47%-3.86M80.96%-3.18M119.40%12.99M44.35%-3.66M43.99%-5.02M-5.70%-7.5M-123.65%-16.71M30.58%5.92M-33.38%-6.58M-136.74%-8.96M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 48.47%-3.86M80.96%-3.18M119.40%12.99M44.35%-3.66M43.99%-5.02M-5.70%-7.5M-123.65%-16.71M30.58%5.92M-33.38%-6.58M-136.74%-8.96M
Basic earnings per share 50.00%-0.0880.00%-0.07107.69%0.2742.86%-0.0842.11%-0.11-6.67%-0.16-118.75%-0.3530.00%0.13-27.27%-0.14-137.50%-0.19
Diluted earnings per share 50.00%-0.0880.00%-0.07125.00%0.2742.86%-0.0842.11%-0.11-6.67%-0.16-118.75%-0.3533.33%0.12-27.27%-0.14-137.50%-0.19
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg
Concept CAR-T Therapy
CAR-T Therapy
Intraday+0.79%